TRACK 1: Inspiring Innovation in Formulation, Bioprocessing, and Drug Delivery
Category: Poster Abstract
Dominik Brandstetter (he/him/his)
Coriolis Pharma Research GmbH
Martinsried, Germany
Dominik Brandstetter (he/him/his)
Coriolis Pharma Research GmbH
Martinsried, Germany
Andrea Arsiccio (he/him/his)
Coriolis Pharma Research GmbH
Martinsried, Bayern, Germany
Tim Menzen (he/him/his)
Coriolis Pharma Research GmbH
Matrinsried, Bayern, Germany
Hristo Svilenov (he/him/his)
Technical University, Germany
Figure 1. Effect of chamber pressure and shelf temperature on the risk of process failure during primary drying of F1. Process conditions in blue result in a predicted risk of failure below 5%, which was computed assuming a maximum primary drying time of 50 hours. The selected, more aggressive primary drying protocol is highlighted by a black rectangle.
Figure 2. (A) Cake volume fraction obtained for F1 by conservative (plane bar) and aggressive (dotted bar) primary drying processes, for all neighbor conditions (3-6 neighbors, 3N-6N). (B) Particle concentrations (for particles ≥ 5 µm) detected by MFI in F1. (C) ParticleSentryAI similarities indices (0= similar, 1= dissimilar) in 6N vials after the F1 conservative lyophilization process (red), 4N vials after the F1 aggressive lyophilization process (green), and F1 vial after stir stress (blue).